WSTAM
Wilbanks Smith & Thomas Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $1.21M | Sell |
2,088
-220
| -10% | -$128K | 0.03% | 209 |
|
2023
Q4 | $1.23M | Buy |
2,308
+18
| +0.8% | +$9.55K | 0.04% | 199 |
|
2023
Q3 | $1.16M | Buy |
2,290
+94
| +4% | +$47.6K | 0.04% | 208 |
|
2023
Q2 | $1.15M | Buy |
2,196
+82
| +4% | +$42.8K | 0.04% | 207 |
|
2023
Q1 | $1.22M | Buy |
2,114
+100
| +5% | +$57.6K | 0.04% | 197 |
|
2022
Q4 | $1.11M | Sell |
2,014
-287
| -12% | -$158K | 0.04% | 206 |
|
2022
Q3 | $1.17M | Buy |
2,301
+180
| +8% | +$91.3K | 0.05% | 201 |
|
2022
Q2 | $1.15M | Buy |
2,121
+294
| +16% | +$160K | 0.05% | 205 |
|
2022
Q1 | $998K | Sell |
1,827
-118
| -6% | -$64.5K | 0.04% | 219 |
|
2021
Q4 | $1.3M | Sell |
1,945
-20
| -1% | -$13.3K | 0.05% | 207 |
|
2021
Q3 | $1.12M | Buy |
1,965
+13
| +0.7% | +$7.43K | 0.04% | 214 |
|
2021
Q2 | $985K | Hold |
1,952
| – | – | 0.04% | 226 |
|
2021
Q1 | $891K | Buy |
1,952
+299
| +18% | +$136K | 0.04% | 221 |
|
2020
Q4 | $770K | Sell |
1,653
-51
| -3% | -$23.8K | 0.04% | 217 |
|
2020
Q3 | $752K | Buy |
1,704
+379
| +29% | +$167K | 0.04% | 198 |
|
2020
Q2 | $480K | Sell |
1,325
-462
| -26% | -$167K | 0.03% | 245 |
|
2020
Q1 | $507K | Sell |
1,787
-239
| -12% | -$67.8K | 0.04% | 216 |
|
2019
Q4 | $658K | Sell |
2,026
-31
| -2% | -$10.1K | 0.04% | 213 |
|
2019
Q3 | $599K | Buy |
2,057
+12
| +0.6% | +$3.49K | 0.04% | 205 |
|
2019
Q2 | $601K | Sell |
2,045
-13
| -0.6% | -$3.82K | 0.04% | 205 |
|
2019
Q1 | $563K | Buy |
2,058
+78
| +4% | +$21.3K | 0.04% | 223 |
|
2018
Q4 | $443K | Sell |
1,980
-312
| -14% | -$69.8K | 0.03% | 216 |
|
2018
Q3 | $559K | Buy |
2,292
+285
| +14% | +$69.5K | 0.03% | 224 |
|
2018
Q2 | $416K | Buy |
2,007
+182
| +10% | +$37.7K | 0.03% | 219 |
|
2018
Q1 | $377K | Buy |
1,825
+205
| +13% | +$42.3K | 0.03% | 227 |
|
2017
Q4 | $308K | Sell |
1,620
-37
| -2% | -$7.04K | 0.02% | 265 |
|
2017
Q3 | $314K | Buy |
1,657
+116
| +8% | +$22K | 0.03% | 246 |
|
2017
Q2 | $269K | Buy |
1,541
+185
| +14% | +$32.3K | 0.02% | 253 |
|
2017
Q1 | $208K | Buy |
+1,356
| New | +$208K | 0.02% | 303 |
|
2016
Q4 | – | Sell |
-1,360
| Closed | -$216K | – | 331 |
|
2016
Q3 | $216K | Buy |
+1,360
| New | +$216K | 0.02% | 262 |
|